{"organizations": [], "uuid": "5386c258938d44d752db52a70f2d3084d33f6e20", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180329.html", "section_title": "Archive News &amp; Video for Thursday, 29 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-reata-announces-that-kyowa-hakko-k/brief-reata-announces-that-kyowa-hakko-kirin-received-sakigake-priority-review-designation-for-bardoxolone-methyl-in-japan-idUSFWN1RB0Z3", "country": "US", "domain_rank": 408, "title": "Reata Announces That Kyowa Hakko Kirin Received Sakigake Priority Review Designation For Bardoxolone Methyl In Japan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.157, "site_type": "news", "published": "2018-03-30T04:29:00.000+03:00", "replies_count": 0, "uuid": "5386c258938d44d752db52a70f2d3084d33f6e20"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-reata-announces-that-kyowa-hakko-k/brief-reata-announces-that-kyowa-hakko-kirin-received-sakigake-priority-review-designation-for-bardoxolone-methyl-in-japan-idUSFWN1RB0Z3", "ord_in_thread": 0, "title": "Reata Announces That Kyowa Hakko Kirin Received Sakigake Priority Review Designation For Bardoxolone Methyl In Japan", "locations": [], "entities": {"persons": [], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "reata pharmaceuticals inc", "sentiment": "negative"}, {"name": "kyowa hakko kirin", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29 (Reuters) - Reata Pharmaceuticals Inc:\n* REATA ANNOUNCES THAT KYOWA HAKKO KIRIN RECEIVED SAKIGAKE PRIORITY REVIEW DESIGNATION FOR BARDOXOLONE METHYL IN JAPAN Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-30T04:29:00.000+03:00", "crawled": "2018-03-30T12:57:21.000+03:00", "highlightTitle": ""}